Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Dexlansoprazole Sesquihydrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 466Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
    Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada

    27 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240227281018/en

    BUSINESSWIRE
    27 Feb 2024
    Share Share
    TWi's Generic Dexlansoprazole Receives Approval in the U.S.
    TWi's Generic Dexlansoprazole Receives Approval in the U.S.

    16 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202666

    FDA
    16 Sep 2022
    Share Share
    Par Pharm’s Generic Dexlansoprazole Receives Approval In US
    Par Pharm’s Generic Dexlansoprazole Receives Approval In US

    20 Apr 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202294

    FDA
    20 Apr 2017
    Share Share
    Takeda’s Dexlansoprazole Received Approval In US
    Takeda’s Dexlansoprazole Received Approval In US

    26 Oct 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/takedas-dexlansoprazole-received-approval-in-us-1477649737.pdf

    FDA
    26 Oct 2016
    Share Share
    Nexium Lawsuit Launched by Bernstein Liebhard LLP Link PPI to Kidney Failure
    Nexium Lawsuit Launched by Bernstein Liebhard LLP Link PPI to Kidney Failure

    05 May 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/nexium-lawsuit-investigation-launched-by-bernstein-liebhard-llp-after-two-studies-link-proton-pump-inhibitors-to-chronic-kidney-disease-kidney-failure-300263926.html

    PR NEWSWIRE
    05 May 2016
    Share Share
    FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)
    FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)

    28 Jan 2016

    // PRNEWSWIRE

    http://www.prnewswire.com/news-releases/fda-approves-takedas-dexilant-solutab-dexlansoprazole-300210700.html

    PRNEWSWIRE
    28 Jan 2016
    Share Share